Treatment of rheumatoid arthritis with etanercept with reference to disease-modifying anti-rheumatic drugs: long-term safety and survival using prospective, observational data

Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies

(2012) Juan Antonio Avina-Zubieta et al.   ANNALS OF THE RHEUMATIC DISEASES

Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis

(2011) X. Mariette et al.   ANNALS OF THE RHEUMATIC DISEASES

Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

(2011) A. Strangfeld et al.   ANNALS OF THE RHEUMATIC DISEASES

No evidence of association between anti-tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register

(2010) Mark Lunt et al.   ARTHRITIS AND RHEUMATISM

Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation

(2010) Joanna Stanczyk et al.   ARTHRITIS AND RHEUMATISM

Lymphoma, rheumatoid arthritis, and TNFα antagonists

(2010) Xavier Mariette   JOINT BONE SPINE

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly

(2010) J. B. Galloway et al.   RHEUMATOLOGY

Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis

(2010) B. J. Radovits et al.   ARTHRITIS CARE & RESEARCH

Systematic review and meta-analysis: Anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis

(2010) Cheryl Barnabe et al.   ARTHRITIS CARE & RESEARCH

The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis

(2009) Johan Askling et al.   CURRENT OPINION IN RHEUMATOLOGY